INTRODUCTION
============

In every stage of production pigs can encounter pathogens that may cause detrimental effects on growth performance and health. In the U.S., 2 newly-emerged enteric pathogens which compromise health and production are porcine epidemic diarrhea virus (**PEDV**) and porcine deltacoronavirus (**PDCoV**). Both of these RNA viruses are of the *Coronaviridae* family ([@r34]) that infect enterocytes of the gastrointestinal tract. In April 2013, PEDV was first identified in the U.S. ([@r27]) with clinical signs including diarrhea, dehydration, anorexia, and mortality. Severe clinical signs and mortality have been primarily observed in suckling pigs ([@r27]); however, PEDV clinical signs are also observed in weaned pigs with varying levels of morbidity ([@r21]) in experimental conditions. In February 2014, PDCoV was first detected in the U.S. and was shown to be related to 2 Chinese strains with clinical signs of diarrhea in sows and piglets and mortality in piglets ([@r30]). The majority of research on PDCoV has focused on etiology, propagation in cell culture, and genome sequencing ([@r3]; [@r10]; [@r17]; [@r20]; [@r9]); however, little research is available on the effect of PDCoV on growth performance.

There is a perception that PEDV occurrences are declining and is mainly an issue for neonatal pigs, but there are still new cases of PEDV and PDCoV occurring every week ([@r29]). Interestingly, the long-term effects of PEDV and PDCoV on pig performance and lean tissue accretion have not been reported. Such research can provide critical information as to how long it takes infected pigs to recover from either virus infection, and how the infection affects overall lean accretion. Therefore, our objective was to compare and determine how these 2 coronaviruses modulate nursery pig growth performance and tissue accretion rates over a 6 wk period.

MATERIALS AND METHODS
=====================

The Institutional Animal Care and Use Committee at Iowa State University (Ames, IA) approved all experimental protocols (IACUC\# 11--14--7903-S).

Animals, Housing, Experimental Design, and Diets
------------------------------------------------

A total of 75 maternal line Choice Genetics Large White Pureline Line 3 barrows and gilts (BW = 10.81 ± 0.81 kg) at approximately 2 wk post-wean and naïve for PEDV and PDCoV were selected, weighed, and allotted to treatments.

Pigs were allotted based on BW and sex across 3 treatments with 8 pens per treatment for a 42 d test period. Each pen had 2 to 5 pigs per pen. Treatments were: 1) Control (*n* = 8); 2) PEDV inoculated (*n* = 8); and 3) PDCoV inoculated (*n* = 8). Inoculum of PEDV was administered as previously described ([@r21]). Pen feeder weights and BW were recorded on day post inoculation (**dpi**) 0, 2, 5, 7, and weekly thereafter until dpi 42. Over the first 2 wk, pigs were sequentially removed from each pen on dpi 2, 5, 7, and 14 and euthanized for tissue collection to study the pathogenesis of these viruses. This analyses will be discussed elsewhere. From dpi 14 to 42, there was 1 pig per pen.

All pigs were fed the same corn-soybean meal diet that was formulated to meet or exceed the [@r22] requirements for nutrients and energy ([Table 1](#tbl1){ref-type="table"}). Pigs were allowed free access to feed and water. The diet was analyzed ([Table 1](#tbl1){ref-type="table"}) for DM by oven drying at 135°C for 2 h (method 930.15; [@r2]), concentration of CP was calculated by analyzing N content via a TruMac N (LECO Corporation, St. Joseph, MO) and gross energy using bomb calorimetry (Oxygen Bomb Calorimeter 6200, Parr Instrument Company, Moline, IL). Benzoic acid was used as the standard for bomb calorimeter calibration.

###### 

Diet composition, as-fed basis

  Ingredient                      %, as-fed
  ------------------------------ -----------
  Corn                              60.93
  Soybean meal, 48% CP              30.00
  Corn DDGS^1^                      5.00
  Soybean oil                       1.00
  Limestone                         0.94
  l-lysine HCl                      0.50
  Sodium chloride                   0.35
  Vitamin-mineral pre-mix^2^        0.30
  Monocalcium phosphorous, 21%      0.55
  Heat stable Optiphos 2000^3^      0.02
  l-Threonine                       0.22
  dl-Methionine                     0.19
  Calculated composition         
      CP, %                         21.13
      ME, kcal/kg                   3388
      NE, kcal/kg                   2433
      Lys, SID^4^%                  1.33
      Lys, total %                  1.48
  Analysis                       
      DM, %                         95.21
      CP, %                         21.38
      GE, kcal/kg                   4030

^1^DDGS = distiller\'s dried grains with solubles.

^2^Premix supplied (per kg of diet): 8820 IU vitamin A, 1653 IU vitamin D3, 33.1 IU vitamin E, 4.4 mg vitamin K, 6.6 mg riboflavin, 38.9 mg niacin, 22.1 mg pantothenic acid, 0.04 mg vitamin B12, 1.1 mg I as potassium iodide, 0.30 mg Se as sodium selenite, 60.6 mg Zn as zinc oxide, 36.4 mg Fe as ferrous sulfate, 12.1 mg Mn as manganous oxide, and 3.6 mg Cu as copper sulfate.

^3^Huvepharma Inc., Peachtree City, GA.

^4^SID = standardized ileal digestibility.

Inoculation and Sample Collection
---------------------------------

On dpi 0, PEDV pigs were inoculated with 5 mL of 10^3^ tissue culture infectious dose (**TCID**)50/ml PEDV isolate (USA/Iowa/18984/2013) via intragastric gavage as previously described ([@r8]; [@r21]). For PDCoV pigs, plaque-cloned PDCoV isolate (US/Iowa/25573/2014) from a naturally infected sow showing clinical signs of diarrhea was used. The pigs received 5 mL of the virus at a rate of 103 TCID50/ml via intragastric gavage. Individual pig fecal swabs were taken daily for the first wk to determine virus shedding in the feces ([Table 2](#tbl2){ref-type="table"}). Fecal swabs were subjected to normal diagnostic process via quantitative real-time PCR (**RT-PCR**) testing for PEDV and PDCoV.

###### 

Fecal virus shedding of nursery pigs inoculated with porcine epidemic diarrhea virus (PEDV) or porcine deltacoronavirus (PDCoV)^1^

                              dpi^2^                          
  -------------------------- -------- ------- ------- ------- -------
  Cycle threshold^3^                                          
      Control                 40.00    40.00   40.00   40.00   40.00
      PEDV                    34.73    31.98   30.12   27.49   27.86
      PDCoV                   40.00    39.07   32.98   38.43   39.91
  Positive pigs/total pigs                                    
      Control                  0/25    0/25    0/21    0/21    0/21
      PEDV                     8/25    12/25   16/20   14/20   13/20
      PDCoV                    0/25    2/25    14/21   5/21    0/21

^1^Average cycle threshold of all pigs on test pigs. Positive pigs/total pigs represent pigs with Ct ≤ 37 that were positive for PEDV or PDCoV out of the total number of pigs sampled.

^2^dpi = day post inoculation.

^3^Cycle threshold (Ct) for positive = ≤ 37, suspect = 38 to 40, negative ≥ 40.

In brief, fecal swabs were processed on the day of collection. In brief, fecal swabs were added to 2 mL of PBS (pH 7.4) without calcium and magnesium (GIBCO/Fischer Scientific, Pittsburg, PA). Samples were vortexed, centrifuged, and the supernatant was collected and stored at -80°C. Viral RNA was extracted using the MagMAX Viral RNA Isolation Kit (Life Technologies/Fisher Scientific, Pittsburg, PA) using the manufacturer\'s instructions for high-volume extraction. Reverse transcription quantitative PCR was performed as previously described ([@r21]) with viral standards of known infectivity titers for quantification. A cycle threshold (**Ct**) less than or equal to 37 was considered positive for virus, 38 to 39 was considered suspect, and greater than or equal to 40 was considered negative.

Whole Body Composition and Tissue Accretion
-------------------------------------------

One pig per pen was designated for longitudinal assessment of body composition at dpi -3 and at the end of the study (dpi 42). These 24 pigs were selected based on the average BW. This initial and final whole body composition was assessed using nondestructive dual-energy X-ray absorptiometry (**DXA**; Hologic Discovery A, Bedford, MA) as previously described ([@r28]). Briefly, all pigs were fasted overnight prior to scanning and the designated 24 body composition pigs were then removed from their pens, anesthetized via intramuscular injection with telazol:ketamine:xylozene (2:1:2; 4.4 mg/kg BW and 2.2 mg/kg BW, respectively) at a dosage rate of 1 mL per 45.5 kg BW. Anesthetized pigs were placed on the DXA scan table in sternal recumbancy with fore and hind legs extended. Once scanned, pigs were allowed to recover and then returned to their pens. The DXA output provided information on whole body bone, fat, and lean tissue mass. Scan data was corrected for gut fill and blood volume using internally built calibration curves for pigs using the following regressions: Live weight, y = 1.0822x-1.826, *R*^2^ = 0.9970; Fat, y = 0.9515x-1.06, *R*2 = 0.9308; Bone mineral ash, y = 2.1473x-0.1411, *R*2 = 0.9219; Lean, y = 1.0668x-0.1411, *R*2 = 0.9909; Protein, y = 0.2206x-0.6611, *R*2 = 0.9758; where x = DXA results and y = chemical proximate on an empty whole body (i.e., no luminal, urine or gall bladder contents). These calibration curves where built as described by [@r28].

Calculations and Statistical Analysis
-------------------------------------

Weekly ADG, ADFI, and G:F were calculated using weekly pen feed intake and BW. The accretion rates (g/d) for whole body lean, protein, fat, BW, bone mineral density (**BMD**) and bone mineral content (**BMC**) were calculated by the following formula:
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Data were analyzed using the MIXED procedure in SAS (SAS Inst. Inc., Cary, NC). Pen was the experimental unit for all growth performance parameters. The model included treatment as fixed effect and start BW was used as a covariate. Pig was used as the experimental unit for body composition and tissue accretion analysis. The model included treatment as fixed effect. Least square (**LS**) means of treatments were determined using the LS means statement and differences in LS means were produced using the pdiff option. Data are reported as LS means estimates with a pooled SEM. A *P*-value of 0.05 or lower was used to assess significance and a *P*-value less than 0.10 was considered a tendency.

Change in BW was plotted as a scatter plot using SGPLOT procedure, with regression of the change in BW over time (dpi) with 95% confidence limit around the mean BW per treatment. Predicted BW change per treatment group was determined using the MIXED procedure. The model included treatment and dpi as fixed effects. Pig nested within treatment was used in the repeated statement using spatial power covariance structure. Predicted means were plotted using the SGPLOT procedure regressing the treatment predicted means over time (dpi).

RESULTS
=======

A common diet was fed to all treatments and was formulated to contain 21.13% CP, 3388 ME (kcal/kg), and 1.33% SID Lys on an as-fed basis. The analyzed diet was 95.21% DM, 21.38% CP, and 4030 gross energy (kcal/kg).

Control pigs were negative for PEDV and PDCoV for the entire duration of the study and performed similarly to the predicted performance for similar BW and high health pigs ([@r22]). The NRC predicts ADG and ADFI to be 0.59 kg and 0.95 kg, respectively for pigs weighing 11 to 25 kg, which is similar to the overall Control pig performance. Pigs inoculated with PEDV were confirmed positive via RT-PCR on dpi 1 and continued shedding virus though dpi 5, but were negative for PEDV from dpi 6 through the end of the study ([Table 2](#tbl2){ref-type="table"}). Pigs inoculated with PDCoV became suspect for virus via RT-PCR on dpi 2, were confirmed positive on dpi 3, and all pigs were negative on dpi 6. From this study, PEDV and PDCoV pigs had the highest rate of infection on dpi 3 as indicated by the greater amount of positive pigs out of total pigs sampled.

There was a tendency (*P* = 0.091) for start BW to be different among treatments; therefore, start BW was used as a covariate for all growth performance data ([Table 3](#tbl3){ref-type="table"}). Pigs inoculated with PEDV weighed 15% and 18% less (*P* = 0.012) at the end of 42 d compared with Control pigs and PDCoV pigs, respectively, which were not different from each other. From dpi 0 to 7, PEDV pigs had significantly reduced (*P* \< 0.05) ADG and G:F (78 and 58%, respectively) compared with Control pigs and had a 32% reduction (*P* = 0.013) in ADFI compared to PDCoV pigs. However, pigs inoculated with PDCoV were able to maintain similar (*P* \> 0.05) ADG, ADFI, and G:F to Control pigs from dpi 0 to 7.

###### 

Overall and weekly growth performance in Controls and pigs inoculated with porcine epidemic diarrhea virus (PEDV) or porcine deltacoronavirus (PDCoV) over a 42 d period

                          Treatment              *P*-value          
  ---------------------- ----------- ---------- ----------- ------- ----------
  Start BW, kg              11.06       9.71       11.65     0.605    0.091
  End BW, kg              41.89^a^    35.39^b^   43.39^a^    1.804    0.012
  dpi 0-- 7^1^                                                      
      ADG                  0.49^a^    0.11^b^     0.44^a^    0.038   \< 0.001
      ADFI                0.62^ab^    0.48^b^     0.71^a^    0.047    0.013
      G:F                  0.71^a^    0.13^b^     0.68^a^    0.075   \< 0.001
  dpi 8-- 14                                                        
      ADG                   0.60        0.55       0.64      0.054    0.565
      ADFI                 0.69^b^    0.66^b^     0.94^a^    0.058    0.019
      G:F                   0.88        0.86       0.68      0.089    0.308
  dpi 15-- 21                                                       
      ADG                   0.79        0.69       0.58      0.076    0.144
      ADFI                  1.19        1.06       1.34      0.104    0.211
      G:F                  0.67^a^    0.67^a^     0.42^b^    0.045    0.002
  dpi 22-- 28                                                       
      ADG                   0.80        0.74       1.01      0.108    0.197
      ADFI                  1.29        1.15       1.49      0.122    0.173
      G:F                   0.62        0.68       0.70      0.085    0.807
  dpi 29-- 42                                                       
      ADG                   0.86        0.80       0.87      0.043    0.493
      ADFI                  1.77        1.72       1.82      0.138    0.873
      G:F                   0.50        0.48       0.48      0.040    0.781
  Overall (dpi 0-- 42)                                              
      ADG                   0.73        0.64       0.72      0.056    0.489
      ADFI                 1.00^a^    0.81^b^     1.11^a^    0.059    0.011
      G:F                   0.74        0.76       0.66      0.055    0.486

^a,b^Means with differing superscripts indicate a significant (*P* \< 0.05) difference.

^1^dpi = days post inoculation.

From dpi 8 to 14, PEDV pigs had a 30% reduction (*P* = 0.019) in ADFI compared with PDCoV pigs, but were similar to Control pigs. In contrast, pigs inoculated with PDCoV consumed 27% more feed per d compared with Control pigs. However, all treatments had similar (*P* \> 0.05) G:F from dpi 8 to 14. From dpi 15 to 21, pigs inoculated with PDCoV had a 37% reduction in G:F compared with Control and PEDV pigs, which were not statistically different from each other. Weekly performance from 22 to 42 dpi, showed no difference (*P* \> 0.05) in ADG, ADFI, and G:F among treatment groups. From 0 to 42 dpi, pigs inoculated with PEDV had a 19 and 27% reduction (*P* = 0.011) in ADFI compared with Control and PDCoV pigs, respectively. The overall reduction in ADFI is primarily driven by the reductions in ADFI and feed efficiency during dpi 0 to 7 which agrees with the peak impact of PEDV being within dpi 0 to 7 as indicated by number of positive pigs for fecal viral shedding. The rate of BW change was plotted over the 42 d period ([Fig. 1](#fig1){ref-type="fig"}). The rate was similar for Control and PDCoV pigs; however, the rate of BW change was visibly decreased for PEDV pigs.
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There was no difference (*P* \> 0.05) in initial body composition among pigs including: fat, lean, lean to fat ratio, BW, BMC, and BMD ([Table 4](#tbl4){ref-type="table"}). Pigs inoculated with PEDV had a 22 and 27% reduction (*P* = 0.018) in final whole body fat mass compared with Control and PDCoV pigs, respectively, which were not different from each other. Similarly, PEDV pigs had a 15 and 17% reduction (*P* = 0.012) in final whole body lean mass compared with Control and PDCoV pigs, respectively, which were not different form each other. There was a tendency (*P* = 0.056) for PEDV pigs to have greater lean to fat ratio compared with PDCoV pigs, but were not different from Control pigs. The DXA predicted BW reported a 16 and 18% reduction (*P* = 0.012) in final BW for PEDV pigs compared with Control and PDCoV pigs, respectively. Similar trends were observed for final whole body protein mass, final BMC, and final BMD where PEDV pigs had less final whole body protein mass (*P* = 0.013), final BMC (*P* = 0.034), and final BMD (*P* = 0.029) compared with Control and PDCoV pigs.

###### 

Initial and final body composition, and accretion of fat, lean, protein, BW, bone mineral content (BMC), and bone mineral density (BMD) in Controls and pigs inoculated with porcine epidemic diarrhea virus (PEDV) or porcine deltacoronavirus (PDCoV) from dpi -3 to 42^1^

                          Treatment              *P*-value          
  ---------------------- ----------- ---------- ----------- ------- -------
  Initial composition                                               
      Fat, kg               0.88        0.80       0.84      0.08    0.736
      Lean, kg              8.93        9.01       8.59      0.68    0.899
      Protein, kg           1.23        1.24       1.17      0.11    0.899
      Lean:Fat              10.43      11.62       10.55     0.68    0.421
      BW, kg                10.02       9.97       9.65      0.76    0.931
      BMC^2^,     kg        0.23        0.25       0.25      0.02    0.589
      BMD^3^, g/cm^3^       0.40        0.40       0.40      0.01    0.984
  Final composition                                                 
      Fat, kg              5.55^a^    4.35^b^     5.96^a^    0.34    0.018
      Lean, kg            37.12^a^    31.69^b^   38.05^a^    1.47    0.012
      Protein, kg          6.14^a^    5.13^b^     6.31^a^    0.27    0.013
      Lean:Fat            6.83^ab^    7.34^a^     6.49^b^    0.24    0.059
      BW, kg              44.15^a^    37.25^b^   45.64^a^    1.91    0.012
      BMC^2^, kg           0.69^a^    0.52^b^     0.73^a^    0.06    0.034
      BMD^3^, g/cm^3^     0.68^ab^    0.63^b^     0.71^a^    0.02    0.029
  Whole body accretion                                              
      Total body, g/d     726.1^a^    580.4^b^   734.6^a^    38.65   0.016
      Fat, g/d             99.3^a^    75.8^b^    104.6^a^    7.69    0.034
      Lean, g/d           599.8^a^    482.6^b^   601.2^a^    30.06   0.015
      Protein, g/d        104.5^a^    82.8^b^    104.9^a^    5.54    0.014
      BMC^2^, g/d          9.8^a^      5.7^b^     9.9^a^     1.04    0.014

^a,b^Means with differing superscripts indicate a significant (*P* \< 0.05) difference.

^1^Initial composition was determined by dual x-ray absorptiometry (DXA) scan 3 d prior to inoculation. Final composition was determined by DXA scan at 42 dpi. Whole body accretion was calculated by (corrected final composition-- corrected initial composition)/d on test.

^2^BMC = bone mineral content.

^3^BMD = bone mineral density.

Whole body protein accretion rates ([Table 4](#tbl4){ref-type="table"}) of Control pigs (104.5 g/d) was similar to that estimated for this size pig by the [@r22] modeling at 105 g/d. Pigs inoculated with PEDV had a 24 and 28% reduction (*P* = 0.034) in whole body fat accretion compared with Control and PDCoV pigs, respectively, which were not different from each other. In PEDV pigs, whole body lean and protein accretion was reduced (*P* = 0.015) by 20 and 21% compared with Control and PDCoV pigs, respectively, which did not differ from each other. The DXA predicted whole body accretion rates were similar to scale based overall ADG as reported in [Table 3](#tbl3){ref-type="table"} (Controls 0.73 vs. 0.73 kg/d; PEDV 0.58 vs. 0.64 kg/d; and PDCoV 0.73 vs. 0.73 kg/d, respectively). For PEDV pigs, the whole body accretion rate were 20 and 21% less than Control and PDCoV pigs, respectively which was similar to the scale-based reduction in overall ADG of 16 and 18%, respectively.

DISCUSSION
==========

Pigs that have poor health status or are raised in conditions of high pathogen loads have antagonized growth performance. This is evident in work by [@r31], [@r32], [@r33], in which grow-finish pigs raised in unsanitary conditions have reduced ADG, G:F, and predicted lean accretion. Further, [@r6] showed that nursery pigs challenged with porcine reproductive and respiratory syndrome virus (**PRRSV**) had profoundly impacted whole body protein accretion. This was particularly evident in the first week of PRRSV infection where whole protein accretion is impeded up to 60% from negative pigs and up to 33% in wk 2 ([@r6]). In weaned pigs, PRRSV infection has also been shown to decrease ADFI and G:F ratios within the first 14 dpi compared with negative pigs ([@r25]). Interestingly, there is limited data showing the extent to which enteric pathogens alter pig feed efficiency, body composition and tissue accretion rates.

Enteric viruses infect the gastrointestinal tract typically causing clinical signs of diarrhea and dehydration with varying degrees of morbidity, and mortality. These clinical signs may be due to altered digestive function and gut integrity. Nursery pigs infected with PEDV have been shown to have decreased brush border digestive enzymes ([@r14]) and redistribution of tight junction proteins zona-occludin 1 and E-cadherin ([@r16]). In addition, growing pigs inoculated with PEDV showed increased permeability and decreased intestinal integrity in the jejunum as indicated by increased FITC-dextran permeability and decreased transepithelial electrical resistance, respectively, compared with negative pigs ([@r26]). These changes at the gastrointestinal tract level are evident during periods of high pathogen load; however, the long-term impacts on growth performance and lean accretion have not been reported.

The viral shedding pattern of PEDV observed in this study was as expected in this age pig and is consistent with previous literature that reports viral shedding after dpi 1 ([@r21]; [@r15]; [@r18]). [@r18] observed viral shedding through dpi 7 compared with [@r21] who observed viral shedding until dpi 24; however, pigs were different sizes, 2 kg and 6.5 kg, respectively and inoculum dose and strain differed between studies. As with PEDV, PDCoV onset of viral shedding is relatively quick (within dpi 0 to 2). The viral shedding period in PDCoV pigs was 3 d and fairly consistent among pigs. In suckling pigs (∼2 kg BW), viral shedding was variable where some pigs began to shed virus at dpi 2 and others at dpi 5 ([@r3]). [@r20] orally inoculated four 10 d-old piglets with 10^6^ plaque-forming units (**PFU**) of PDCoV and observed clinical signs of diarrhea at dpi 1, peak viral shedding at dpi 7, and viral persistence in feces through dpi 21. Pigs in this study had an average start BW of 10.81 kg and may have had a more developed immune system ([@r1]) compared with younger pigs used in aforementioned studies and variability in age, genetics, health status, diet, inoculum strain virulence, inoculum dose, and housing conditions, etc., may influence viral shedding among studies.

Pathogens can be recognized by macrophages which respond by secreting cytokines to initiate an immune response and cytokines such as interleukin (IL)-1β, IL-6 and tumor necrosis factor (TNF)-ɑ have been shown to decrease appetite ([@r12]). This information, along with published performance data of PEDV and PDCoV infected pigs ([@r19]; [@r3]; [@r20]; [@r26]), led us to expect a reduction in ADG, ADFI, and G:F in pigs inoculated with either PEDV or PDCoV. Pigs inoculated with PEDV have been reported to have severe reductions in ADG (-18 g/d) compared to their negative counterparts (27 g/d) after 7 dpi ([@r19]). In pigs that were similar in size to our current study and inoculated with the same PEDV strain, there was a 29% decrease in ADFI for PEDV pigs compared with negative pigs ([@r26]) which was similar to the 23% reduction during dpi 0 to 7 which was not statistically significant in the current study. However, this paper reported a 47 and 28% reductions in ADG and G:F, respectively, of pigs inoculated with PEDV which was less than our observed reduction of 78 and 58%, for ADG and G:F, respectively, during dpi 0 to 7. Although we observed a decrease in feed efficiency from dpi 0 to 7, we did not observe an overall effect of PEDV on 42 d feed efficiency.

To our knowledge, feed intake and feed efficiency of pigs inoculated with PDCoV has not been published. However, there have been reports of ADG and BW changes due to PDCoV challenges. [@r3] inoculated 5-d old pigs with 10 mL of 3 × 10^3^ TCID~50~/mL of a cell culture isolate of PDCoV (USA/IL/2014), and reported that after dpi 4 and 7, PDCoV pigs did not differ in BW or ADG compared with negative pigs. However, in 10 d-old pigs, [@r20] observed a 10 to 15% reduction in BW of pigs inoculated with 10^6^ PFU of PDCoV, MI strain compared with negative pigs after dpi 10. We did not observe a difference in ADG or G:F of PDCoV pigs compared with Control pigs. As with PEDV, these differences may be due to strain of PDCoV used, virulence of inoculum, age, genetics, housing conditions, or health status. For both PEDV and PDCoV, we did not observe any differences in growth performance after dpi 21 compared with Control pigs. This indicates that pigs infected with either of these viruses at this BW can recover and begin to perform similar to their negative counterparts. However, the initial impact of PEDV on ADFI and ADG will increase the number of d to reach a desirable final market weight compared to negative pigs.

The data herein is the first report on whole body tissue accretion rates of pigs inoculated with PEDV and PDCoV that we are aware of. In our study, we determined that PEDV decreased lean, protein, fat, and BMC accretion compared with Control pigs over a 6 wk period, but PDCoV did not differ from the Control pigs. There are few published studies on the effect of an immune challenge on whole body composition and tissue accretion of pigs ([@r5]; [@r6]; [@r7]). [@r5] and [@r6] used the serial slaughter technique to determine whole body composition and calculated tissue accretion rates. After 7 d of PRRSV infection in 4 wk-old pigs, there was a 41 and 63% reduction in protein and lipid accretion, respectively, compared with negative pigs ([@r6]). After 80 d of PRRSV infection in pigs (start BW = 33 kg), there was a 14% reduction in lean and protein accretion and an 18% reduction in fat accretion compared with negative pigs ([@r7]). These studies show that PRRSV not only impacts short-term tissue accretion, but also reduces tissue accretion long-term. Peak viremia of PRRSV is usually within 7 d after inoculation ([@r13]; [@r11]) and reduced feed intake is observed within dpi 0 to 14 ([@r26]) which may explain a bigger reduction in tissue accretion during a shorter time period after onset of infection. During an immune challenge, there is a demand for energy and nutrients at a time that is coupled with reduced feed intake. This situation may cause mobilization of AA and FA from muscle and adipose, respectively, thus altering body composition. Pigs inoculated with PEDV had severe reductions in ADFI within and began to perform similar to Control pigs after dpi 21, but we still observed reductions in tissue accretion over 42 d for PEDV pigs.

The observed decrease in protein accretion for PEDV compared with Control pigs may be due to overall decreased feed intake and thus, energy and AA are repartitioned in different tissues in the body. In 26-d old pigs, immune stimulation, as initiated by lipopolysaccharide (**LPS**) injection, increased circulating total AA concentrations during the fasted state ([@r23]). In rotavirus-infected pigs, total circulating AA concentrations were also increased during the fed state ([@r24]). Increasing circulating AA concentration during an immune stimulation indicates that the body is repartitioning its AA pool to tissues in need of AA and one of the major AA pools in the body is muscle. In fasted 7-d and 26-d old piglets, LPS injection was used to determine severity of muscle degradation during systemic inflammation ([@r23]). Despite the high protein turnover rate in 7-d old piglets compared with 26-d old piglets ([@r4]), both age groups had increased abundance of proteins involved with skeletal muscle degradation including: NF-ϗB, caspase 3, AMPK, E3 ligases (MuRF1 and atrogin1), and cleaved ɑ-actin, a result of muscle proteolysis.

Enteric infections have been shown to modulate protein synthesis machinery in a tissue dependent manner ([@r24]). One of the main pathways involved in protein synthesis is the mammalian target of rapamycin (**mTOR**) pathway. This pathway is regulated by many inputs including energy and amino acid status, stress, and growth factors. Two proteins downstream of mTOR that are thought to be involved in the initiation of protein synthesis are p70^s6k^ and its downstream target ribosomal protein S6. In rotavirus-challenged 4-d old pigs, protein abundance of total and activated (phosphorylated) p70^S6K^ were increased during peak infection in the jejunum compared to negative pigs ([@r24]). In that study, another group of pigs was rotavirus-infected and malnourished by diluting the complete formula by 50% with an electrolyte solution. Regardless of having reduced energy intake, the malnourished-infected pigs also had increased protein abundance of total and activated (phosphorylated) p70^S6K^ in the jejunum. However, in the muscle of both infected groups, there was a reduction of total S6 protein during peak infection compared to healthy controls. A reduction in protein synthesis in the muscle agrees with the current study that there was a decrease in protein accretion in PEDV pigs. The degradation occurring in the muscle most likely is due to the increased demand of AA in the intestine to aid in recovery of the epithelium. This indicates that the effects of enteric challenges are not driven by reduced feed intake alone, but there are post-absorptive changes during an enteric challenge that can lead to changes in body composition due to metabolic shifts within tissues.

In conclusion, reductions in tissue accretion and feed intake appear to be pathogen specific. We determined that overall 6 wk reductions in tissue accretion and ADFI were only observed in PEDV, but not in PDCoV inoculated pigs. We could not determine from this study if the reduction in tissue accretion is primarily driven by the reduction in feed intake, changes in digestibility, or other modifications to post-absorptive metabolism resulting from the PEDV challenge itself. Regardless, the energy and AA requirements of health-challenged pigs may be different from their healthy counterparts during infection and warrants further investigation.
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